blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3941460

EP3941460 - METHOD FOR IMPROVING INSULIN SENSITIVITY [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  08.03.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  24.12.2021
FormerThe international publication has been made
Status updated on  28.09.2020
Most recent event   Tooltip13.09.2024New entry: Reply to examination report 
Applicant(s)For all designated states
Nieman, Lynnette K.
Building 10/CRC, Room 1-3140, 10 Center Drive
Bethesda, MD 20892 / US
For all designated states
Ulmann, André
23 rue Pascal
75005 Paris / FR
For all designated states
Newman, Arnold L.
P.O. Box 171
Cabin John, MD 20818 / US
[2022/04]
Inventor(s)01 / see applicant
...
 [2022/04]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2022/04]
Application number, filing date20774479.809.03.2020
[2022/04]
WO2020US00009
Priority number, dateUS201962919496P18.03.2019         Original published format: US 201962919496 P
[2022/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020190351
Date:24.09.2020
Language:EN
[2020/39]
Type: A1 Application with search report 
No.:EP3941460
Date:26.01.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 24.09.2020 takes the place of the publication of the European patent application.
[2022/04]
Search report(s)International search report - published on:US24.09.2020
(Supplementary) European search report - dispatched on:EP25.11.2022
ClassificationIPC:A61K31/567, A61K31/4745, A61K31/513, A61K31/57, A61K31/585, A61K31/365, A61K45/06, A61P3/04, A61P3/06, A61P3/08, A61P3/10
[2022/52]
CPC:
A61K45/06 (EP,KR,US); A61K31/567 (EP,KR,US); A61K31/4745 (EP,KR,US);
A61K31/513 (EP,KR,US); A61K31/57 (EP,KR,US); A61K31/585 (EP,KR);
A61P3/04 (EP); A61P3/06 (EP); A61P3/08 (EP,KR,US);
A61P3/10 (EP); A61K2300/00 (KR) (-)
C-Set:
A61K31/4745, A61K2300/00 (EP);
A61K31/513, A61K2300/00 (EP);
A61K31/567, A61K2300/00 (EP);
A61K31/57, A61K2300/00 (EP);
A61K31/585, A61K2300/00 (EP)
(-)
Former IPC [2022/04]A61K31/365
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/04]
TitleGerman:VERFAHREN ZUR VERBESSERUNG DER INSULINEMPFINDLICHKEIT[2022/04]
English:METHOD FOR IMPROVING INSULIN SENSITIVITY[2022/04]
French:PROCÉDÉ PERMETTANT D'AMÉLIORER LA SENSIBILITÉ À L'INSULINE[2022/04]
Entry into regional phase12.10.2021National basic fee paid 
12.10.2021Search fee paid 
12.10.2021Designation fee(s) paid 
12.10.2021Examination fee paid 
Examination procedure12.10.2021Examination requested  [2022/04]
14.07.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
14.09.2023Amendment by applicant (claims and/or description)
13.03.2024Despatch of a communication from the examining division (Time limit: M06)
11.09.2024Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
14.09.2023Request for further processing filed
14.09.2023Full payment received (date of receipt of payment)
Request granted
02.11.2023Decision despatched
Fees paidRenewal fee
25.02.2022Renewal fee patent year 03
27.03.2023Renewal fee patent year 04
08.03.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]US5073548  (COOK C EDGAR [US], et al) [YD] 10,11 * column 1, lines 14-67 *;
 [IY]WO0152833  (CORTENDO AB [SE], et al) [I] 1-5,7-9 * page 2, line 20 - page 3, line 25 * * claims 1, 2, 29 * [Y] 10-12;
 [IY]US2002147336  (DOW ROBERT L [US], et al) [I] 1-3,6-9,13,14 * page 10, paragraphs [0193], [0208] * * claims 62, 68 * [Y] 10-12;
 [XY]WO03009853  (CORCEPT THERAPEUTICS INC [US], et al) [X] 1-9,13,14 * page 3, lines 15-17 * * page 8, lines 15-18 * * page 9, lines 2-4 * * page 10, lines 22-31 * * page 12, line 19 - page 16, line 17 * * pages 26-27; examples 1-2 * * claims 1, 8, 9-14 * [Y] 10-12;
 [IY]US2009088425  (BAILLY JACQUES [FR], et al) [I] 1-3,6-9,13-15 * page 1, paragraphs [0002], [0006], [0008]-[0009] * * page 16, paragraph [0377] * [Y] 10-12;
 [XY]  - DEBONO MIGUEL ET AL, "Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study", PLOS ONE, vol. 8, no. 4, doi:10.1371/journal.pone.0060984, (20130101), page e60984, URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0060984&type=printable, XP055981535 [X] 1-5,7-9,15 * abstract * * page 1, column 1, paragraph 1 - page 2, column 1, paragraph 1 * * page 5, column 1, paragraph 1 * * page 5, column 2, paragraph 2 * * page 6; table 2 * * page 7, column 2, paragraph 3 * [Y] 10-12

DOI:   http://dx.doi.org/10.1371/journal.pone.0060984
 [IY]  - Anonymous, "History of Changes for Study: NCT03052400 Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus", ClinicalTrials.gov archive, (20170101), pages 1 - 7, URL: https://www.clinicaltrials.gov/ct2/history/NCT03052400?V_2=View#StudyPageTop, (20221115), XP055981665 [I] 1-5,7-9 * Study description, conditions; page 3 * * Arms and interventions; page 3 * [Y] 10-12
 [Y]  - CHU J W ET AL, "Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, (20010801), vol. 86, no. 8, doi:10.1210/JC.86.8.3568, ISSN 0021-972X, pages 3568 - 3573, XP002410091 [Y] 12 * abstract * * page 3572 *

DOI:   http://dx.doi.org/10.1210/jc.86.8.3568
 [T]  - GUBBI SRIRAM ET AL, "Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, US, vol. 106, no. 5, doi:10.1210/clinem/dgab046, ISSN 0021-972X, (20210423), pages 1501 - 1515, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063260/, XP055981608 [T] 1-15 * abstract * * page 1506; table 2 * * page 1508, column 2, paragraph l - page 1510, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1210/clinem/dgab046
International search[Y]US6166013  (COGHLAN MICHAEL J [US], et al) [Y] 10 * ; col6 col7 col16 *;
 [X]US2002147336  (DOW ROBERT L [US], et al) [X] 16-18 * ; Abstract para[0208] *;
 [A]US2004214804  (GULVE ERIC ARTHUR [US], et al) [A] 1-5, 7-24* ; entire document *;
 [A]US2005080061  (BELANOFF JOSEPH K [US]) [A] 17-18, 24 * ; Abstract *;
 [XY]US2009088425  (BAILLY JACQUES [FR], et al) [X] 1-5, 7, 11-15 * ; Abstract para[0007] para[0020] para[0059] para[0382] * [Y] 8-10, 19-23;
 [X]CN102204918  (UNIV XIAMEN) [X] 24 * ; Abstract p3 *;
 [Y]US2012028358  (SOLODUSHKO VICTOR [US], et al) [Y] 19-21 * ; para[0094] *;
 [Y]  - "miricorilantum", WHO Drug Information. Proposed INN: List 119, (20180000), vol. 32, no. 2, pages 283 - 398, XP055741138 [Y] 8-9 * ; p329 *
 [Y]  - CLORE et al., "When Is Cortisol a Mineralocorticoid?", Kidney International, (19921200), vol. 42, no. 6, doi:10.1038/ki.1992.421, pages 1297 - 1308, XP055741141 [Y] 22-23 * ; p1297, p1298 *

DOI:   http://dx.doi.org/10.1038/ki.1992.421
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.